Enhancement of the immune response and protection induced by probiotic lactic acid bacteria against furunculosis in rainbow trout (Oncorhynchus mykiss)

被引:199
作者
Luis Balcazar, Jose [1 ]
de Blas, Ignacio [1 ]
Ruiz-Zarzuela, Imanol [1 ]
Vendrell, Daniel [1 ]
Girones, Olivia [1 ]
Luis Muzquiz, Jose [1 ]
机构
[1] Univ Zaragoza, Lab Fish Pathol, Zaragoza, Spain
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2007年 / 51卷 / 01期
关键词
probiotics; colonization; humoral and cellular response; prevention; furunculosis; rainbow trout;
D O I
10.1111/j.1574-695X.2007.00294.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We analysed the effect of probiotic strains on the cellular and humoral immune responses of rainbow trout (Oncorhynchus mykiss), and their capacity to prevent furunculosis during a challenge trial. Probiotic strains (Lactococcus lactis ssp. lactis CLFP 100, Leuconostoc mesenteroides CLFP 196, and Lactobacillus sakei CLFP 202) were administered orally to fish for 2 weeks at 10(6) CFU g(-1) of feed. In comparison to untreated control fish, the phagocytic activity of head kidney leukocytes and the alternative complement activity in serum were significantly greater in all probiotic groups at the end of the second week. With the exception of the group fed with Lactobacillus sakei, superoxide anion production was also significantly increased in the probiotic groups. Analysis of lysozyme activity did not exhibit any significant difference in the probiotic and control groups. Fifteen days after the start of the probiotic feeding, fish were challenged with Aeromonas salmonicida ssp. salmonicida. The fish supplemented with probiotics exhibited survival rates ranging from 97.8% to 100%, whereas survival was 65.6% in fish not treated with the probiotics. These results demonstrate that probiotic supplementation to fish can reduce the severity of furunculosis, and suggest that this reduction may be associated with enhanced humoral and cellular immune response.
引用
收藏
页码:185 / 193
页数:9
相关论文
共 44 条
[41]   Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 [J].
Steidler, L ;
Neirynck, S ;
Huyghebaert, N ;
Snoeck, V ;
Vermeire, A ;
Goddeeris, B ;
Cox, E ;
Remon, JP ;
Remaut, E .
NATURE BIOTECHNOLOGY, 2003, 21 (07) :785-789
[42]   Treatment of murine colitis by Lactococcus lactis secreting interleukin-10 [J].
Steidler, L ;
Hans, W ;
Schotte, L ;
Neirynck, S ;
Obermeier, F ;
Falk, W ;
Fiers, W ;
Remaut, E .
SCIENCE, 2000, 289 (5483) :1352-1355
[43]  
VENDRELL D, 2007, IN PRESS COMP IMMUNO
[44]  
Yanno T., 1992, TECHNIQUES FISH IMMU, P131